To investigate the molecular changes in doxorubicin resistance HeLa cell line.
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP394658
下载链接
链接失效反馈官方服务：
资源简介：
Our research has demonstrated combinatorial therapies, repurposing of HDAC inhibitor and chloroquine for reversing the doxorubicin induced resistance in cervical cancer cells. However, in vivo combinatorial treatment of targeting chromatin alterations and autophagy with doxorubicin will be a step forward in translating the concept of overcoming doxorubicin resistance in cervical cancer,
创建时间：
2023-01-28
